1. Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703). (25th June 2021) Authors: Chi, Yihebali; Shu, Yongqian; Ba, Yi; Bai, Yuxian; Qin, Baoli; Wang, Xiuwen; Xiong, Jianping; Xu, Nong; Zhang, Helong; Zhou, Jianfeng; Xu, Jianming; Cheng, Ying; Feng, Jifeng; Hu, Chunhong; Chen, Yigui; Chen, Zhendong; Wang, Jufeng; Dang, Chengxue; Wang, Jianhong; Wan, Yiye Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703). (25th June 2021) Authors: Chi, Yihebali; Shu, Yongqian; Ba, Yi; Bai, Yuxian; Qin, Baoli; Wang, Xiuwen; Xiong, Jianping; Xu, Nong; Zhang, Helong; Zhou, Jianfeng; Xu, Jianming; Cheng, Ying; Feng, Jifeng; Hu, Chunhong; Chen, Yigui; Chen, Zhendong; Wang, Jufeng; Dang, Chengxue; Wang, Jianhong; Wan, Yiye Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: e1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial. Issue 1 (24th May 2019) Authors: Shi, Yuankai; Li, Jin; Xu, Jianming; Sun, Yan; Wang, Liwei; Cheng, Ying; Liu, Wei; Sun, Guoping; Chen, Yigui; Bai, Li; Zhang, Yiping; He, Xiaohui; Luo, Yi; Wang, Zhehai; Liu, Yunpeng; Yao, Qiang; Li, Yuhong; Qin, Shukui; Hu, Xiaohua; Bi, Feng Journal: Cancer communications Issue: Volume 39:Issue 1(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MicroRNA-30c-2-3p represses malignant progression of gastric adenocarcinoma cells via targeting ARHGAP11A. Issue 6 (1st June 2022) Authors: Zheng, Liang; Cai, Xiongchao; Song, Jintian; Shi, Huaijing; Zhang, Jiulong; Ke, Xi; Li, Hui; Chen, Yigui Journal: Bioengineered Issue: Volume 13:Issue 6(2022) Page Start: 14534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety. (9th December 2021) Authors: Song, Jintian; Wang, Yi; Yu, Hui; Zheng, Liang; Cai, Xiongchao; Chen, Yigui Other Names: Huang Tao Academic Editor. Journal: Computational and mathematical methods in medicine Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗